BlackRock Fund Advisors’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$5.48M Buy
1,178,520
+154,324
+15% +$905K ﹤0.01% 2890
2016
Q3
$7.93M Buy
1,024,196
+55,209
+6% +$355K ﹤0.01% 2595
2016
Q2
$5.87M Sell
968,987
-12,558
-1% -$102K ﹤0.01% 2700
2016
Q1
$8.36M Buy
981,545
+22,712
+2% +$199K ﹤0.01% 2460
2015
Q4
$11.4M Buy
958,833
+26,779
+3% +$338K ﹤0.01% 2367
2015
Q3
$9.39M Buy
932,054
+1,724
+0.2% +$25.7K ﹤0.01% 2409
2015
Q2
$15.4M Buy
930,330
+120,629
+15% +$1.91M ﹤0.01% 2270
2015
Q1
$12.5M Buy
809,701
+45,977
+6% +$696K ﹤0.01% 2323
2014
Q4
$12.1M Buy
763,724
+212,553
+39% +$2.77M ﹤0.01% 2341
2014
Q3
$5.88M Sell
551,171
-15,816
-3% -$147K ﹤0.01% 2654
2014
Q2
$5.32M Buy
566,987
+107,926
+24% +$690K ﹤0.01% 2798
2014
Q1
$3.17M Buy
459,061
+10,616
+2% +$62.8K ﹤0.01% 3040
2013
Q4
$1.75M Buy
448,445
+5,410
+1% +$21.9K ﹤0.01% 3153
2013
Q3
$2.23M Buy
443,035
+153,719
+53% +$940K ﹤0.01% 3109
2013
Q2
$1.85M Buy
+289,316
New +$1.85M ﹤0.01% 3109

Other funds holding TGTX